[go: up one dir, main page]

IL319227A - Psilocin crystalline forms - Google Patents

Psilocin crystalline forms

Info

Publication number
IL319227A
IL319227A IL319227A IL31922725A IL319227A IL 319227 A IL319227 A IL 319227A IL 319227 A IL319227 A IL 319227A IL 31922725 A IL31922725 A IL 31922725A IL 319227 A IL319227 A IL 319227A
Authority
IL
Israel
Prior art keywords
psilocin
crystalline forms
crystalline
forms
psilocin crystalline
Prior art date
Application number
IL319227A
Other languages
Hebrew (he)
Inventor
Jim Gilligan
Peter Guzzo
Original Assignee
Tryp Therapeutics Inc
Jim Gilligan
Peter Guzzo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tryp Therapeutics Inc, Jim Gilligan, Peter Guzzo filed Critical Tryp Therapeutics Inc
Publication of IL319227A publication Critical patent/IL319227A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16Tryptamines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01Sulfonic acids
    • C07C309/28Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/29Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/124Acids containing four carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/02Dicarboxylic acids
    • C07C55/10Succinic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/13Dicarboxylic acids
    • C07C57/145Maleic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/13Dicarboxylic acids
    • C07C57/15Fumaric acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235Saturated compounds containing more than one carboxyl group
    • C07C59/245Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/265Citric acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C63/00Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
    • C07C63/04Monocyclic monocarboxylic acids
    • C07C63/06Benzoic acid
    • C07C63/08Salts thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL319227A 2022-09-12 2023-09-12 Psilocin crystalline forms IL319227A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202263375305P 2022-09-12 2022-09-12
PCT/IB2023/059011 WO2024057193A1 (en) 2022-09-12 2023-09-12 Psilocin crystalline forms

Publications (1)

Publication Number Publication Date
IL319227A true IL319227A (en) 2025-04-01

Family

ID=90274467

Family Applications (1)

Application Number Title Priority Date Filing Date
IL319227A IL319227A (en) 2022-09-12 2023-09-12 Psilocin crystalline forms

Country Status (6)

Country Link
EP (1) EP4587426A1 (en)
JP (1) JP2025530158A (en)
AU (1) AU2023343417A1 (en)
CA (1) CA3267523A1 (en)
IL (1) IL319227A (en)
WO (1) WO2024057193A1 (en)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB912715A (en) * 1958-02-21 1962-12-12 Sandoz Ltd 4-hydroxytryptamines
US20080293695A1 (en) * 2007-05-22 2008-11-27 David William Bristol Salts of physiologically active and psychoactive alkaloids and amines simultaneously exhibiting bioavailability and abuse resistance
AU2022218986A1 (en) * 2021-02-10 2023-09-21 Eleusis Therapeutics Us, Inc. Pharmaceutically acceptable salts of psilocin and uses thereof
CN117177959A (en) * 2021-03-18 2023-12-05 赛本爱尔兰有限公司 Nudity analogs, salts, compositions, and methods of use
CA3219041A1 (en) * 2021-05-24 2022-12-01 Canna-Chemistries Llc Crystalline salts of psilocin
EP4486448A1 (en) * 2022-03-04 2025-01-08 Reset Pharmaceuticals, Inc. Co-crystals or salts comprising psilocin
US11667607B1 (en) * 2022-06-30 2023-06-06 Zylorion Health Inc. Crystalline forms of compositions comprising psilocin and psilocybin

Also Published As

Publication number Publication date
EP4587426A1 (en) 2025-07-23
JP2025530158A (en) 2025-09-11
AU2023343417A1 (en) 2025-03-13
CA3267523A1 (en) 2024-03-21
WO2024057193A1 (en) 2024-03-21

Similar Documents

Publication Publication Date Title
GB202102360D0 (en) Crystalline compound
GB202200735D0 (en) Compounds
IL323224A (en) Crystalline form
IL321171A (en) 2-oxoquinazoline crystalline forms
GB202208643D0 (en) Compounds
IL319227A (en) Psilocin crystalline forms
GB202300021D0 (en) Compounds
GB202214796D0 (en) Compounds
GB202208151D0 (en) Compounds
GB202201996D0 (en) Compounds
GB202217726D0 (en) Crystalline compound
IL314730A (en) Crystalline (+)-tetrabenazine
GB202218027D0 (en) Psilocin prodrugs
GB202210427D0 (en) Psilocin prodrugs
GB202008588D0 (en) Crystalline forms
GB202317989D0 (en) Novel crystalline salt forms
GB202308164D0 (en) Compounds
GB202302871D0 (en) Compounds
GB202302237D0 (en) Tryptophan-based compounds
GB202300995D0 (en) Compounds
GB202301012D0 (en) Compounds
GB202301000D0 (en) Compounds
GB202301008D0 (en) Compounds
GB202301024D0 (en) Compounds
GB202300922D0 (en) Compounds